Table 2.
IC50 for cytotoxicity and IC50 for antioxidant activity of BCZO bionanoplatforms
| Sample | IC50 for cytotoxicity | IC50 for antioxidant activity | |
|---|---|---|---|
| µg/mL | DPPH assay | ABTS assay | |
| µg/mL | µg/mL | ||
| BCZO | 354.29 ± 2.4 | 78.64 ± 0.42 | 84.38 ± 0.47 |
| BCZO/HPEC | 337.73 ± 0.49 | 27.46 ± 0.16 | 37.39 ± 0.24 |
| Cc@BCZO/HPEC | 354.46 ± 2.87 | 54.86 ± 0.29 | 60.39 ± 0.33 |
| Pp@BCZO/HPEC | 350.39 ± 1.87 | 97.15 ± 0.56 | 103.50 ± 0.59 |
| Cc/Pp50@BCZO/HPEC | 333.45 ± 0.83 | 47.48 ± 0.25 | 51.53 ± 0.26 |
| Cc/Pp100@BCZO/HPEC | 162.28 ± 0.39 | 35.65 ± 0.21 | 45.65 ± 0.28 |